Greater Baltimore Medical Center is a hospital located in the Baltimore suburb of Towson, Maryland. GBMC serves more than 20,455 inpatient cases and approximately 52,000 emergency department visits annually.

There are 231 beds in Greater Baltimore Medical Center.

During the past decade, Greater Baltimore Medical Center conducted 105 clinical trials. In the 10-year time frame, 105 clinical trials started and 116 clinical trials were completed, i.e. on average, 110.5% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 67 clinical trials were completed. i.e. 239.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Greater Baltimore Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 91 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Gynecologic Oncology Group" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored and "NSABP Foundation Inc" with 8 trials sponsored. Other sponsors include 98 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Greater Baltimore Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "NRG Oncology" with 39 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "Genentech, Inc." with 6 trials as a collaborator. Other collaborators include 129 different institutions and companies that were collaborators in the rest 88 trials.

According to Clinical.Site data, the most researched conditions in "Greater Baltimore Medical Center" are "Breast Cancer" (11 trials), "Fallopian Tube Transitional Cell Carcinoma" (10 trials), "Ovarian Endometrioid Adenocarcinoma" (10 trials), "Ovarian Seromucinous Carcinoma" (10 trials) and "Recurrent Ovarian Carcinoma" (10 trials). Many other conditions were trialed in "Greater Baltimore Medical Center" in a lesser frequency.

Most popular intervention types in "Greater Baltimore Medical Center" are "Drug" (173 trials), "Other" (112 trials), "Biological" (73 trials), "Radiation" (38 trials) and "Procedure" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (67 trials), "Quality-of-Life Assessment" (46 trials), "Paclitaxel" (42 trials), "Carboplatin" (34 trials) and "Questionnaire Administration" (26 trials). Other intervention names were less common.

The vast majority of trials in "Greater Baltimore Medical Center" are 143 trials for "All" genders, 86 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Greater Baltimore Medical Center". undefined are not yet recruiting, 31 are recruiting, 92 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 82 completed trials in Greater Baltimore Medical Center, 2 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Greater Baltimore Medical Center, 8 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 125 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 17 trials that are defined as “Not Applicable".

Greater Baltimore Medical Center has several departments that took part in Clinical trials: "Greater Baltimore Medical Center and Cancer Center" - 73 trials